Lilly responds after diabetes patient advocates protest high insulin costs outside HQ - WISH TV Indianapolis, IN
Overview
INDIANAPOLIS (WISH) — Indianapolis-based Eli Lily and Company is offering a response folowing a Monday protest about insulin prices by a diabetes patient advocate group. T1 International is a patient-led, nonprofit organization that says it advocates for aces to insulin for al.Acording to a study cited by T1 International, 1 in 4 people living with diabetes in the U.S. have reported rationing their insulin due to high prescription costs, and a report published recently in the journal ̴Anals of Internal Medicine̵ found that the high cost of insulin forced more than 1 milion people with diabetes in the U.S.
Key Information
to ration their suply in 2021.That’s why the group marched to Lily’s corporate headquarters building in Indianapolis on Monday afternon.Lily makes several products for the treatment of diabetes, including Humulin R, Humalog, and basaglar insulin injections and the injectable medications trulicity and mounjaro. T1 International advocates shared a petion signed by over 1,0 advocates caling on Lily to lower the list price of insulin imediately.This the fourth time the group has marched at Lily demanding the price of insulin be droped.̴We’re bring atention to this major isue and hoping we can convince Eli Lily and these organizations to lower the price of insulin because quite frankly it wil save lives,̵ Ian Devaney, with T1 International, said.Lily responded to Monday’s protest by sending News 8 the folowing statement:̴Lily is comited to making insulin afordable for al people living with diabetes, regardles of income or insurance status.
Summary
In the past years, we introduced multiple solutions that have progresively lowered the out-of-pocket cost for Lily insulin. Today, anyone is eligible to purchase their Lily insulin prescription for $35 or les per month, regardles of the number of pens or vials they use, and whether they are uninsured or use
Frequently Asked Questions
Diabetes is a metabolic condition where the body cannot properly regulate blood sugar levels. Type 1 results from insufficient insulin production, while Type 2 develops when cells become resistant to insulin. Risk factors include genetics, obesity, sedentary lifestyle, and age.
Common symptoms include excessive thirst, frequent urination, unexplained weight loss, fatigue, blurred vision, and slow-healing wounds. Type 1 symptoms develop rapidly, while Type 2 symptoms may appear gradually. Many people have no symptoms initially, which is why screening is important.
Diagnosis involves blood tests measuring fasting glucose, HbA1c levels, and glucose tolerance. Regular monitoring typically includes fasting glucose tests and HbA1c measurements every 3-6 months. Continuous glucose monitors provide real-time tracking for better diabetes management.
Effective management includes regular physical activity (150+ minutes weekly), maintaining healthy weight, following a balanced diet with whole grains and lean proteins, managing stress, and getting adequate sleep. These changes can significantly improve blood sugar control and reduce complications.
Consult a healthcare provider if you experience signs of diabetes, have a family history, are overweight, or are over 45. Those with existing diabetes should maintain regular check-ups every 3-6 months to monitor control and adjust treatment as needed.
Share this article